Clinical study and comprehensive management strategies of complications related to transcatheter tricuspid valve therapy_West China Medical Journal

Authors：

NING Xiaoping ,  QIAO Fan

Department of Cardiovascular Surgery, Changhai Hospital Affiliated to the Naval Medical University, Shanghai 200433, P. R. China;

Corresponding author：

QIAO Fan, Email: qiaofan@smmu.edu.cn

Keywords：

Tricuspid regurgitation; transcatheter; complication; prevention and control

DOI：

10.7507/1002-0179.202509145

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

With the advancement of interventional cardiology, transcatheter tricuspid valve intervention has become an important treatment option for patients with severe tricuspid regurgitation who are at high surgical risk. This article provides a systematic summary of the types, incidence, risk factors, and management strategies of complications related to transcatheter tricuspid valve repair and replacement. This article also discusses the pathophysiological mechanisms and preventive measures of right heart dysfunction, device malanchoring, and renal impairment. Multimodality imaging, device innovation, and individualized anticoagulation strategies are crucial for reducing complications. Long-term follow-up data are needed to refine complication management strategies and promote the safe application of transcatheter tricuspid valve intervention.

Citation： NING Xiaoping, QIAO Fan. Clinical study and comprehensive management strategies of complications related to transcatheter tricuspid valve therapy. West China Medical Journal, 2025, 40(10): 1557-1562. doi: 10.7507/1002-0179.202509145 Copy

1.	Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol, 2004, 43(3): 405-409.
2.	Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol, 2017, 70(24): 2953-2960.
3.	Davidson LJ, Tang GHL, Ho EC, et al. The tricuspid valve: a review of pathology, imaging, and current treatment options: a scientific statement from the american heart association. Circulation, 2024, 149(22): e1223-e1238.
4.	Lu FL, An Z, Ma Y, et al. Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation. Heart, 2021, 107(20): 1664-1670.
5.	Angellotti D, Mattig I, Samim D, et al. Early outcomes of real-world transcatheter tricuspid valve replacement. JACC Cardiovasc Interv, 2025, 18(15): 1896-1909.
6.	Pan X, Lu F, Wang Y, et al. Transcatheter tricuspid valve replacement with the novel system: 1-year outcomes from the TRAVEL study. JACC Cardiovasc Interv, 2025, 18(10): 1276-1285.
7.	Lurz P, Rommel KP, Schmitz T, et al. Real-world 1-year results of tricuspid edge-to-edge repair from the bRIGHT Study. J Am Coll Cardiol, 2024, 84(7): 607-616.
8.	Davidson CJ, Lim DS, Smith RL, et al. Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes. JACC Cardiovasc Interv, 2021, 14(1): 41-50.
9.	Rangavajla G, Patel R, Nguyen F, et al. Atrioventricular block after EVOQUE transcatheter tricuspid valve replacement. Struct Heart, 2025, 9(9): 100701.
10.	Teiger E, Nejjari M, Lim P, et al. First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system. EuroIntervention, 2022, 18(10): 862-864.
11.	Buğan B, Çekirdekçi Eİ, Onar LÇ, et al. Transcatheter tricuspid valve replacement for tricuspid regurgitation: a systematic review and meta-analysis. Anatol J Cardiol, 2022, 26(7): 505-519.
12.	Kodali S, Hahn RT, George I, et al. Transfemoral tricuspid valve replacement in patients with tricuspid regurgitation: TRISCEND study 30-day results. JACC Cardiovasc Interv, 2022, 15(5): 471-480.
13.	Mathis MR, Duggal NM, Likosky DS, et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology, 2019, 131(5): 1046-1062.
14.	王渝强, 石峻, 刘路路, 等. 经导管三尖瓣介入术后肺部并发症的初次探索及康复建议: 前瞻性队列研究. 中国胸心血管外科临床杂志, 2022, 29(8): 963-970.
15.	Safi LM, Lerakis S, Tang GHL, et al. Intraprocedural guidance for transcatheter tricuspid valve replacement in challenging scenarios. JACC Cardiovasc Imaging, 2025, 18(3): 382-388.
16.	Tanaka T, Vogelhuber J, Öztürk C, et al. Eligibility for transcatheter tricuspid valve interventions in patients with tricuspid regurgitation. JACC Cardiovasc Interv, 2024, 17(23): 2732-2744.
17.	Gerçek M, Goncharov A, Narang A, et al. Characterization of screen failures among patients evaluated for transcatheter tricuspid valve repair (TriSelect-Study). JACC Cardiovasc Interv, 2023, 16(13): 1579-1589.
18.	Weckbach LT, Stolz L, Doldi PM, et al. Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right-sided heart failure. Eur J Heart Fail, 2024: doi: 10.1002/ejhf.3529.
19.	Lurz P, Orban M, Besler C, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J, 2020, 41(29): 2785-2795.
20.	Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv, 2020, 13(21): 2482-2493.
21.	Dreyfus J, Audureau E, Bohbot Y, et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J, 2022, 43(7): 654-662.
22.	Zorman MJ, Vibhishanan J, Dangas K, et al. Subclinical and clinical valve thrombosis after transcatheter tricuspid valve replacement: a systematic review and meta-analysis. JACC Cardiovasc Interv, 2025, 18(11): 1495-1497.
23.	Braunstein ED, Simsolo E, Kassam N, et al. Cardiac implantable electronic device implantation and function after transcatheter tricuspid valve replacement. Heart rhythm, 2025: S1547-5271(25)02730-4.
24.	Peigh G, Al-Kazaz M, Davidson LJ, et al. Outcomes of entrapped right ventricular pacing or defibrillator leads following transcatheter tricuspid valve replacement. JACC Cardiovasc Interv, 2025, 18(14): 1762-1772.
25.	Patrascu A, Binder D, Al Farwan F, et al. Two ‘firsts’ in a patient with tricuspid valve infective endocarditis following edge-to-edge repair: a case report. Eur Heart J Case Rep, 2024, 8(4): ytae181.
26.	Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J, 2023, 44(39): 3948-4042.Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J, 2023, 44(39): 3948-4042.
27.	Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis, 2019, 62(6): 447-451.
28.	Stolz L, Fam N, Ong G, et al. Transcatheter tricuspid valve replacement using the LuX-Valve Plus system: 1-year compassionate use outcomes. Eur J Heart Fail, 2025. doi: 10.1002/ejhf.70010.

1. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol, 2004, 43(3): 405-409.
2. Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol, 2017, 70(24): 2953-2960.
3. Davidson LJ, Tang GHL, Ho EC, et al. The tricuspid valve: a review of pathology, imaging, and current treatment options: a scientific statement from the american heart association. Circulation, 2024, 149(22): e1223-e1238.
4. Lu FL, An Z, Ma Y, et al. Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation. Heart, 2021, 107(20): 1664-1670.
5. Angellotti D, Mattig I, Samim D, et al. Early outcomes of real-world transcatheter tricuspid valve replacement. JACC Cardiovasc Interv, 2025, 18(15): 1896-1909.
6. Pan X, Lu F, Wang Y, et al. Transcatheter tricuspid valve replacement with the novel system: 1-year outcomes from the TRAVEL study. JACC Cardiovasc Interv, 2025, 18(10): 1276-1285.
7. Lurz P, Rommel KP, Schmitz T, et al. Real-world 1-year results of tricuspid edge-to-edge repair from the bRIGHT Study. J Am Coll Cardiol, 2024, 84(7): 607-616.
8. Davidson CJ, Lim DS, Smith RL, et al. Early feasibility study of cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes. JACC Cardiovasc Interv, 2021, 14(1): 41-50.
9. Rangavajla G, Patel R, Nguyen F, et al. Atrioventricular block after EVOQUE transcatheter tricuspid valve replacement. Struct Heart, 2025, 9(9): 100701.
10. Teiger E, Nejjari M, Lim P, et al. First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system. EuroIntervention, 2022, 18(10): 862-864.
11. Buğan B, Çekirdekçi Eİ, Onar LÇ, et al. Transcatheter tricuspid valve replacement for tricuspid regurgitation: a systematic review and meta-analysis. Anatol J Cardiol, 2022, 26(7): 505-519.
12. Kodali S, Hahn RT, George I, et al. Transfemoral tricuspid valve replacement in patients with tricuspid regurgitation: TRISCEND study 30-day results. JACC Cardiovasc Interv, 2022, 15(5): 471-480.
13. Mathis MR, Duggal NM, Likosky DS, et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology, 2019, 131(5): 1046-1062.
14. 王渝强, 石峻, 刘路路, 等. 经导管三尖瓣介入术后肺部并发症的初次探索及康复建议: 前瞻性队列研究. 中国胸心血管外科临床杂志, 2022, 29(8): 963-970.
15. Safi LM, Lerakis S, Tang GHL, et al. Intraprocedural guidance for transcatheter tricuspid valve replacement in challenging scenarios. JACC Cardiovasc Imaging, 2025, 18(3): 382-388.
16. Tanaka T, Vogelhuber J, Öztürk C, et al. Eligibility for transcatheter tricuspid valve interventions in patients with tricuspid regurgitation. JACC Cardiovasc Interv, 2024, 17(23): 2732-2744.
17. Gerçek M, Goncharov A, Narang A, et al. Characterization of screen failures among patients evaluated for transcatheter tricuspid valve repair (TriSelect-Study). JACC Cardiovasc Interv, 2023, 16(13): 1579-1589.
18. Weckbach LT, Stolz L, Doldi PM, et al. Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right-sided heart failure. Eur J Heart Fail, 2024: doi: 10.1002/ejhf.3529.
19. Lurz P, Orban M, Besler C, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J, 2020, 41(29): 2785-2795.
20. Hahn RT, Kodali S, Fam N, et al. Early multinational experience of transcatheter tricuspid valve replacement for treating severe tricuspid regurgitation. JACC Cardiovasc Interv, 2020, 13(21): 2482-2493.
21. Dreyfus J, Audureau E, Bohbot Y, et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J, 2022, 43(7): 654-662.
22. Zorman MJ, Vibhishanan J, Dangas K, et al. Subclinical and clinical valve thrombosis after transcatheter tricuspid valve replacement: a systematic review and meta-analysis. JACC Cardiovasc Interv, 2025, 18(11): 1495-1497.
23. Braunstein ED, Simsolo E, Kassam N, et al. Cardiac implantable electronic device implantation and function after transcatheter tricuspid valve replacement. Heart rhythm, 2025: S1547-5271(25)02730-4.
24. Peigh G, Al-Kazaz M, Davidson LJ, et al. Outcomes of entrapped right ventricular pacing or defibrillator leads following transcatheter tricuspid valve replacement. JACC Cardiovasc Interv, 2025, 18(14): 1762-1772.
25. Patrascu A, Binder D, Al Farwan F, et al. Two ‘firsts’ in a patient with tricuspid valve infective endocarditis following edge-to-edge repair: a case report. Eur Heart J Case Rep, 2024, 8(4): ytae181.
26. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J, 2023, 44(39): 3948-4042.Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J, 2023, 44(39): 3948-4042.
27. Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis, 2019, 62(6): 447-451.
28. Stolz L, Fam N, Ong G, et al. Transcatheter tricuspid valve replacement using the LuX-Valve Plus system: 1-year compassionate use outcomes. Eur J Heart Fail, 2025. doi: 10.1002/ejhf.70010.

Previous Article
Progress of transcatheter tricuspid valve replacement treatment device
Next Article
Interpretation of Chinese Expert Consensus on Transcatheter Tricuspid Valve Intervention Therapy

West China Medical Journal

Clinical study and comprehensive management strategies of complications related to transcatheter tricuspid valve therapy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content